跳至主要内容
临床试验/JPRN-UMIN000005817
JPRN-UMIN000005817招募中未知

The Effect of Using Candesarsan and Amlodipine for Hypertensive Patients with Dyslipidemia in Japan - EARTH-trial

The Cardiovascular Institute0 个研究点目标入组 40 人开始时间: 2011年6月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Malignancy 2.Contraindication to take candesartan, amlodipine and pitabastatin. 3.Familial hypercholesterolemia 4.Acute coronary syndrome 5.Already enrollment other clinical trials. 6.Mismatched patients

研究者

发起方
The Cardiovascular Institute

相似试验

Unknown
2 期
A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionEssential Hypertension
NCT02206165Chong Kun Dang Pharmaceutical456
进行中(未招募)
1 期
Effet de l’association fixe amlodipine/valsartan sur la Pression artérielle centrale chez des hypertendus essentiels non contrôlés par amlodipine 5mg - Etude EXPLORHypertension artérielle essentielleMedDRA version: 9.1Level: LLTClassification code 10020775Term: Hypertension arterial
EUCTR2006-006733-41-FRovartis Pharma S.A.S.532
已完成
不适用
Effect of combination therapy with amlodipine and atorvastatin on blood pressure varaiability, vascular function and renal function in hypertensive patients with chronic kidney diseaseHypertension with chronic kidney disease (CKD stage 1-4)
JPRN-UMIN000009045Yokohama city university hospital50
已完成
3 期
effects of amlodipine to reduce cardiac iron overloadMajor Thalasemia.Beta thalassemiaD56.1
IRCT20190829044642N1Arak University of Medical Sciences30
进行中(未招募)
不适用
A TElmisartan and AMlodipine STudy to Assess the cardiovascular PROTECTive effects as measured by endothelial dysfunction in hypertensive at risk patients beyond blood pressure - TEAMSTA PROTECT I?Male and female, treated and treatment-naive patients with uncontrolled hypertension (defined as 20/10 mmHg above target BP of <140/90 mmHg [<130/80 mmHg for renally impaired and/ or diabetics patients])?Male and female treated patients with controlled hypertension (defined as target BP < 140/90 mmHg [ < 130/80 mmHg for renally impaired and/ or diabetics patients])MedDRA version: 13.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disorders
EUCTR2009-017010-68-DEniversitätsmedizin der Johannes Gutenberg-Universität Mainz